Adjustment for baseline characteristics in randomized trials using logistic regression: sample-based model versus true model.

Baseline imbalance Over-fitting Randomized clinical trials Simulation study Statistical adjustment

Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
13 Feb 2023
Historique:
received: 31 03 2022
accepted: 26 12 2022
entrez: 14 2 2023
pubmed: 15 2 2023
medline: 16 2 2023
Statut: epublish

Résumé

Adjustment for baseline prognostic factors in randomized clinical trials is usually performed by means of sample-based regression models. Sample-based models may be incorrect due to overfitting. To assess whether overfitting is a problem in practice, we used simulated data to examine the performance of the sample-based model in comparison to a "true" adjustment model, in terms of estimation of the treatment effect. We conducted a simulation study using samples drawn from a "population" in which both the treatment effect and the effect of the potential confounder were specified. The outcome variable was binary. Using logistic regression, we compared three estimates of the treatment effect in each situation: unadjusted, adjusted for the confounder using the sample, adjusted for the confounder using the true effect. Experimental factors were sample size (from 2 × 50 to 2 × 1000), treatment effect (logit of 0, 0.5, or 1.0), confounder type (continuous or binary), and confounder effect (logit of 0, - 0.5, or - 1.0). The assessment criteria for the estimated treatment effect were bias, variance, precision (proportion of estimates within 0.1 logit units), type 1 error, and power. Sample-based adjustment models yielded more biased estimates of the treatment effect than adjustment models that used the true confounder effect but had similar variance, accuracy, power, and type 1 error rates. The simulation also confirmed the conservative bias of unadjusted analyses due to the non-collapsibility of the odds ratio, the smaller variance of unadjusted estimates, and the bias of the odds ratio away from the null hypothesis in small datasets. Sample-based adjustment yields similar results to exact adjustment in estimating the treatment effect. Sample-based adjustment is preferable to no adjustment.

Sections du résumé

BACKGROUND BACKGROUND
Adjustment for baseline prognostic factors in randomized clinical trials is usually performed by means of sample-based regression models. Sample-based models may be incorrect due to overfitting. To assess whether overfitting is a problem in practice, we used simulated data to examine the performance of the sample-based model in comparison to a "true" adjustment model, in terms of estimation of the treatment effect.
METHODS METHODS
We conducted a simulation study using samples drawn from a "population" in which both the treatment effect and the effect of the potential confounder were specified. The outcome variable was binary. Using logistic regression, we compared three estimates of the treatment effect in each situation: unadjusted, adjusted for the confounder using the sample, adjusted for the confounder using the true effect. Experimental factors were sample size (from 2 × 50 to 2 × 1000), treatment effect (logit of 0, 0.5, or 1.0), confounder type (continuous or binary), and confounder effect (logit of 0, - 0.5, or - 1.0). The assessment criteria for the estimated treatment effect were bias, variance, precision (proportion of estimates within 0.1 logit units), type 1 error, and power.
RESULTS RESULTS
Sample-based adjustment models yielded more biased estimates of the treatment effect than adjustment models that used the true confounder effect but had similar variance, accuracy, power, and type 1 error rates. The simulation also confirmed the conservative bias of unadjusted analyses due to the non-collapsibility of the odds ratio, the smaller variance of unadjusted estimates, and the bias of the odds ratio away from the null hypothesis in small datasets.
CONCLUSIONS CONCLUSIONS
Sample-based adjustment yields similar results to exact adjustment in estimating the treatment effect. Sample-based adjustment is preferable to no adjustment.

Identifiants

pubmed: 36782238
doi: 10.1186/s13063-022-07053-7
pii: 10.1186/s13063-022-07053-7
pmc: PMC9924183
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

107

Informations de copyright

© 2023. The Author(s).

Références

J Clin Epidemiol. 2012 May;65(5):474-81
pubmed: 22169080
BMJ. 1999 Jul 17;319(7203):185
pubmed: 10406763
Epidemiology. 1990 Nov;1(6):421-9
pubmed: 2090279
Control Clin Trials. 1998 Jun;19(3):249-56
pubmed: 9620808
Am Heart J. 2000 May;139(5):745-51
pubmed: 10783203
Trials. 2014 Apr 23;15:139
pubmed: 24755011
Stat Med. 1985 Oct-Dec;4(4):437-44
pubmed: 4089348
Contemp Clin Trials. 2011 May;32(3):399-402
pubmed: 21195797
Trials. 2022 Apr 18;23(1):328
pubmed: 35436970
BMC Med Res Methodol. 2009 Jul 27;9:56
pubmed: 19635144

Auteurs

Thomas Perneger (T)

Division of Clinical Epidemiology, University of Geneva and Geneva University Hospitals, 6 Rue Gabrielle-Perret-Gentil, 1211, Geneva, Switzerland. thomas.perneger@hcuge.ch.

Christophe Combescure (C)

Division of Clinical Epidemiology, University of Geneva and Geneva University Hospitals, 6 Rue Gabrielle-Perret-Gentil, 1211, Geneva, Switzerland.

Antoine Poncet (A)

Division of Clinical Epidemiology, University of Geneva and Geneva University Hospitals, 6 Rue Gabrielle-Perret-Gentil, 1211, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH